Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Neurosci Res ; 102(2): e25299, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38361407

RESUMEN

The dopamine D4 receptor 7-repeat allele (D4.7 R) has been linked with psychiatric disorders such as attention-deficit-hyperactivity disorder, autism, and schizophrenia. However, the highly diverse study populations and often contradictory findings make it difficult to draw reliable conclusions. The D4.7 R has the potential to explain individual differences in behavior. However, there is still a great deal of ambiguity surrounding whether it is causally connected to the etiology of psychiatric disorders. Therefore, humanized D4.7 R mice, with the long third intracellular domain of the human D4.7 R, may provide a valuable tool to examine the relationship between the D4.7 R variant and specific behavioral phenotypes. We report that D4.7 R male mice carrying the humanized D4.7 R variant exhibit distinct behavioral features that are dependent on the light-dark cycle. The behavioral phenotype was characterized by a working memory deficit, delayed decision execution in the light phase, decreased stress and anxiety, and increased risk behavior in the dark phase. Further, D4.7 R mice displayed impaired social recognition memory in both the light and dark phases. These findings provide insight into the potential causal relationship between the human D4.7 R variant and specific behaviors and encourage further consideration of dopamine D4 receptor (DRD4) ligands as novel treatments for psychiatric disorders in which D4.7 R has been implicated.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad , Memoria a Corto Plazo , Humanos , Masculino , Ratones , Animales , Dopamina , Receptores de Dopamina D4/genética , Trastorno por Déficit de Atención con Hiperactividad/genética , Trastornos de la Memoria , Asunción de Riesgos
2.
Molecules ; 26(24)2021 Dec 10.
Artículo en Inglés | MEDLINE | ID: mdl-34946576

RESUMEN

Corydalis yanhusuo extract (YHS) has been used for centuries across Asia for pain relief. The extract is made up of more than 160 compounds and has been identified as alkaloids, organic acids, volatile oils, amino acids, alcohols, and sugars. However, the most crucial biological active constituents of YHS are alkaloids; more than 80 have been isolated and identified. This review paper aims to provide a comprehensive review of the phytochemical and pharmacological effects of these alkaloids that have significant ties to analgesia.


Asunto(s)
Alcaloides/uso terapéutico , Analgésicos/uso terapéutico , Corydalis/química , Medicamentos Herbarios Chinos/uso terapéutico , Dolor/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Alcaloides/química , Alcaloides/aislamiento & purificación , Analgésicos/química , Analgésicos/aislamiento & purificación , Medicamentos Herbarios Chinos/química , Medicamentos Herbarios Chinos/aislamiento & purificación , Humanos , Estructura Molecular , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...